The drugs listed are in alphabetical order. Bendamustine hydrochloride injection: Apotex on Jan. 27 reported the discontinuation of both the 25 mg and 100 mg presentations of bendamustine ...
The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...
Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...
Current first-line therapies like allopurinol and febuxostat can be very effective ... hit a target uric acid levels in the blood of 1.5 mg/dL or lower for at least 80% of the sixth months ...
Now, phase 3 results with a new drug from Sobi and ... acid in the blood below the 6 mg/dl threshold, but in some cases, current drugs like allopurinol and febuxostat aren’t able to achieve ...
An investigational drug from Veru helped preserve lean mass in patients taking Wegovy, though some experts raised questions ...
The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...
“If the particulate matter enters the blood vessels, it can travel to various organs and potentially block blood vessels in ...
The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with ...
The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback